---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-045643"
form_type: "8-K"
ticker: "APUS"
cik: "0001894525"
company_name: "Apimeds Pharmaceuticals US, Inc."
filed_at: "2025-05-20T23:59:59+00:00"
generated_at: "2026-05-21T00:31:18.727728+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Apimeds extends maturity of three promissory notes to May 19, 2026

## Summary
- Amended notes from Inscobee ($100k and $150k) and Apimeds Korea ($250k), total $500k principal.
- Original maturity dates extended to May 19, 2026; interest remains 5% per annum.
- May 2024 and August 2024 notes were due May 19, 2025; March 2025 note was due Dec 31, 2026 or upon NYSE listing.
- Amendments executed on May 16, 2025, avoid imminent default on two notes.

## SEC filing metadata
- accession: 0001213900-25-045643
- form_type: 8-K
- ticker: APUS
- cik: 0001894525
- company_name: Apimeds Pharmaceuticals US, Inc.
- filed_at: 2025-05-20T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1894525/000121390025045643/0001213900-25-045643-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1894525/000121390025045643/ea024276701-8k_apimed.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-045643
- JSON: https://secwatch.observer/filing/0001213900-25-045643.json
- Plain text: https://secwatch.observer/filing/0001213900-25-045643.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.